292 related articles for article (PubMed ID: 32455951)
1. Identification of Inhibitors to
Matutino Bastos T; Botelho Pereira Soares M; Haddad Franco C; Alcântara L; Antonini L; Sabatino M; Mautone N; Holanda Freitas-Junior L; Moraes CB; Ragno R; Rotili D; Schenkman S; Mai A; Silvio Moretti N
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455951
[TBL] [Abstract][Full Text] [Related]
2. Chemical Constituents of
Matutino Bastos T; Mannochio Russo H; Silvio Moretti N; Schenkman S; Marcourt L; Gupta MP; Wolfender JL; Ferreira Queiroz E; Botelho Pereira Soares M
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987092
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NAD+-dependent histone deacetylases (sirtuins) causes growth arrest and activates both apoptosis and autophagy in the pathogenic protozoan Trypanosoma cruzi.
Veiga-Santos P; Reignault LC; Huber K; Bracher F; De Souza W; De Carvalho TM
Parasitology; 2014 May; 141(6):814-25. PubMed ID: 24670415
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Trypanosoma cruzi Sirtuins as Possible Drug Targets for Chagas Disease.
Moretti NS; da Silva Augusto L; Clemente TM; Antunes RP; Yoshida N; Torrecilhas AC; Cano MI; Schenkman S
Antimicrob Agents Chemother; 2015 Aug; 59(8):4669-79. PubMed ID: 26014945
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cytoplasmic TcSIR2RP1 and mitochondrial TcSIR2RP3 impacts on Trypanosoma cruzi growth and cell invasion.
Ritagliati C; Alonso VL; Manarin R; Cribb P; Serra EC
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003725. PubMed ID: 25875650
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.
Gaspar L; Coron RP; KongThoo Lin P; Costa DM; Perez-Cabezas B; Tavares J; Roura-Ferrer M; Ramos I; Ronin C; Major LL; Ciesielski F; Pemberton IK; MacDougall J; Ciapetti P; Smith TK; Cordeiro-da-Silva A
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006180. PubMed ID: 29357372
[TBL] [Abstract][Full Text] [Related]
7. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
8. Computational studies on sirtuins from Trypanosoma cruzi: structures, conformations and interactions with phytochemicals.
Sacconnay L; Angleviel M; Randazzo GM; Queiroz MM; Queiroz EF; Wolfender JL; Carrupt PA; Nurisso A
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2689. PubMed ID: 24551254
[TBL] [Abstract][Full Text] [Related]
9. Effect of capsaicin on the protozoan parasite Trypanosoma cruzi.
Valera-Vera EA; Reigada C; Sayé M; Digirolamo FA; Galceran F; Miranda MR; Pereira CA
FEMS Microbiol Lett; 2020 Dec; 367(23):. PubMed ID: 33232444
[TBL] [Abstract][Full Text] [Related]
10. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
11. Phenothiazinium Dyes Are Active against
Bulhões Portapilla G; Pereira LM; Bronzon da Costa CM; Voltarelli Providello M; Sampaio Oliveira PA; Goulart A; Ferreira Anchieta N; Wainwright M; Leite Braga GÚ; de Albuquerque S
Biomed Res Int; 2019; 2019():8301569. PubMed ID: 31355283
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole.
López-Muñoz R; Faúndez M; Klein S; Escanilla S; Torres G; Lee-Liu D; Ferreira J; Kemmerling U; Orellana M; Morello A; Ferreira A; Maya JD
Exp Parasitol; 2010 Feb; 124(2):167-71. PubMed ID: 19735656
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.
Villarreal D; Barnabé C; Sereno D; Tibayrenc M
Exp Parasitol; 2004; 108(1-2):24-31. PubMed ID: 15491545
[TBL] [Abstract][Full Text] [Related]
14. The ubiquinone synthesis pathway is a promising drug target for Chagas disease.
Nara T; Nakagawa Y; Tsuganezawa K; Yuki H; Sekimata K; Koyama H; Ogawa N; Honma T; Shirouzu M; Fukami T; Matsuo Y; Inaoka DK; Kita K; Tanaka A
PLoS One; 2021; 16(2):e0243855. PubMed ID: 33539347
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
[TBL] [Abstract][Full Text] [Related]
16. Anti-Trypanosoma cruzi activity of nicotinamide.
Soares MB; Silva CV; Bastos TM; Guimarães ET; Figueira CP; Smirlis D; Azevedo WF
Acta Trop; 2012 May; 122(2):224-9. PubMed ID: 22281243
[TBL] [Abstract][Full Text] [Related]
17. Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment.
Aguilera E; Varela J; Serna E; Torres S; Yaluff G; Bilbao NV; Cerecetto H; Alvarez G; González M
Mem Inst Oswaldo Cruz; 2018 Mar; 113(3):153-160. PubMed ID: 29412353
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis.
Vela A; Coral-Almeida M; Sereno D; Costales JA; Barnabé C; Brenière SF
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009269. PubMed ID: 33750958
[TBL] [Abstract][Full Text] [Related]
19. Insights into Chagas treatment based on the potential of bacteriocin AS-48.
Martín-Escolano R; Cebrián R; Martín-Escolano J; Rosales MJ; Maqueda M; Sánchez-Moreno M; Marín C
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():1-8. PubMed ID: 30953804
[TBL] [Abstract][Full Text] [Related]
20. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
